Lisa Giles

Lisa Giles is a seasoned professional with extensive experience in the biotechnology and pharmaceutical sectors, currently serving as the Head of Alliance Management at Mundipharma since December 2022. Prior to this role, Lisa held significant positions such as Head of Pipeline & Portfolio Strategy at Gyroscope Therapeutics, where leadership contributed to the expansion of a gene therapy portfolio, and Chief Project and Development Officer at Oxford BioMedica, helping to define company strategy. Additionally, Lisa held various senior leadership roles at CRF Health, Shire, Covance, and Schering-Plough Pharmaceuticals, driving strategic program management and project operations. Lisa holds a 2.1 BSc (Hons) degree in Microbiology and Virology from the University of Warwick and has built a proven track record of fostering high-performing teams and managing complex projects throughout a successful career.